About Elyzora
Pharmaceutical supply chain principals, resident where your product is made
Elyzora establishes a company-side control layer across Asian CMO/CDMO operations. Our principals translate QTPP, CQA, CPP, demand, and commercial requirements into site-level execution controls—compressing release-critical path variance, securing campaign capacity, governing yield and conversion-cost exposure, and strengthening supply continuity for pharmaceutical companies across the U.S., UK, and EU.
Pharmaceutical company operating profiles
Technical governance for outsourced pharmaceutical manufacturing networks
Elyzora supports virtual and specialty pharmaceutical companies, generic and 505(b)(2) asset owners, and commercial portfolio teams across the U.S., UK, and every EU market operating multi-site CDMO/CMO networks across Asia.
We integrate company QTPP, CQA, CPP, demand, and release requirements into site-level execution controls spanning technology transfer, PPQ, material readiness, analytical release, serialization, and GDP dispatch.
Our mandates are measured against operational indicators: right-first-time batch execution, deviation closure, yield variance, schedule adherence, release-cycle compression, capacity protection, and landed COGS.
How we operate
Four operating principles
Presence over correspondence
Governance is exercised inside the plant. Our principals walk the line, review the batch record, and sit in the room when a deviation is raised — not on a call twelve hours later.
Commercial rigor, not opinion
Every conversion fee, yield-loss term, and surcharge is tested against live APAC manufacturing index rates before it is accepted into a master supply agreement.
Accountability you can audit
Scorecards, yield actuals, and corridor performance are documented in formats your quality and finance functions can take directly into their own reviews.
No headcount inflation
You gain an operating capability in Asia without adding permanent regional roles, long-haul travel budgets, or per-inspection consultant fees.
Domain coverage
Where our principals work
United States · United Kingdom · European Union · India · Southeast Asia
- —Finished Dosage Form (FDF) solid orals, semi-solids, and sterile injectables
- —cGMP site qualification, 21 CFR Part 11 and GAMP 5 data integrity review
- —Tech transfer and PPQ campaign supply coordination
- —API/KSM sourcing, dual-sourcing, and stock-out hedging
- —GDP cold-chain lanes, Incoterms, and import documentation
- —Vendor scorecarding and quarterly executive governance
Speak directly with the principals who would run your mandate.